TYRP1 and neoplasm: As depicted in Supplementary Fig. 6, nitroxoline (2.5 or 5 μM) did not significantly reduce CatB protein levels after 24, 48 and 72 h treatment as analyzed with western blot and ELISA, confirming that nitroxoline impairs tumor cell invasion by CatB inhibition.